NEW YORK, March 02, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of PixarBio Corporation securities (OTCQX:PXRB): (1) pursuant and/or traceable to PixarBio’s private placement that closed on October 30, 2016; and/or (2) publicly traded on the open market from October 31, 2016 through January 20, 2017, both dates inclusive (the “Class Period”) of the March 27, 2016 lead plaintiff deadline in the first-filed class action filed by Rosen Law Firm. The lawsuit seeks to recover damages for PixarBio investors under the federal securities laws.
To join the PixarBio class action, go to http://www.rosenlegal.com/cases-1034.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) the market for PixarBio’s securities exhibited manipulative or deceptive activities; (2) PixarBio’s assertions in press releases, third-party promotional materials, and PixarBio’s Form S-1 concerning, among other things, PixarBio’s business combinations and current shareholders; the identity and qualifications of key shareholders and employees and PixarBio’s’ current and prospective development efforts lacked veracity; and; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 27, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1034.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Want to cut your energy bills? Here’s how five experts are doing it
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 



